Frazier Management’s Collegium Pharmaceutical COLL Stock Holding History

Frazier Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-943,666	Closed	-$18.9M	–	36
2020 Q4	$18.9M	Hold	943,666	–	–	1.46%	15
2020 Q3	$19.6M	Hold	943,666	–	–	1.76%	12
2020 Q2	$16.5M	Hold	943,666	–	–	1.45%	14
2020 Q1	$15.4M	Sell	943,666 -943,666	-50%	-$19.5M	1.75%	9
2019 Q4	$38.8M	Hold	1,887,332	–	–	6.51%	5
2019 Q3	$21.7M	Hold	1,887,332	–	–	6.77%	5
2019 Q2	$24.8M	Hold	1,887,332	–	–	6.36%	4
2019 Q1	$28.6M	Hold	1,887,332	–	–	6.88%	3
2018 Q4	$32.4M	Hold	1,887,332	–	–	8.36%	3
2018 Q3	$27.8M	Hold	1,887,332	–	–	5.09%	5
2018 Q2	$45M	Hold	1,887,332	–	–	9.32%	3
2018 Q1	$48.2M	Hold	1,887,332	–	–	8%	2
2017 Q4	$34.8M	Hold	1,887,332	–	–	5.65%	4
2017 Q3	$19.8M	Hold	1,887,332	–	–	7.06%	5
2017 Q2	$23.6M	Hold	1,887,332	–	–	12.1%	3
2017 Q1	$19M	Hold	1,887,332	–	–	10.14%	2
2016 Q4	$29.4M	Hold	1,887,332	–	–	36.98%	1
2016 Q3	$36.4M	Hold	1,887,332	–	–	17.84%	2
2016 Q2	$22.4M	Hold	1,887,332	–	–	17.84%	3
2016 Q1	$34.3M	Buy	1,887,332 +10,000	+0.5%	+$182K	21.08%	2
2015 Q4	$51.6M	Buy	+1,877,332	New	+$39.6M	21.59%	2

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Frazier Management's COLL Position: Q1 2021 in Review

Frazier Management sold out of Collegium Pharmaceutical (COLL) in Q1 2021, closing a stake of 943,666 shares — an estimated $18.9M sold.

Frazier Management first reported a position in COLL in Q4 2015 and held it in 21 quarters. The position peaked at $51.6M in Q4 2015. 163 funds tracked by Wall St. Rank hold COLL as of Q1 2021.

Frazier Management reported no remaining Collegium Pharmaceutical position as of Q1 2021 after selling out during the quarter.
Frazier Management sold 943,666 Collegium Pharmaceutical shares in Q1 2021, an estimated $18.9M.
Frazier Management first reported a position in Collegium Pharmaceutical in Q4 2015 and held it in 21 quarters.
Frazier Management's Collegium Pharmaceutical position peaked at $51.6M in Q4 2015.
163 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2021.

Based on Frazier Management's 13F filing for Q1 2021, filed 12 May 2021.